Biora Therapeutics, Inc., known in the stock market as BIOR.US, has achieved a significant milestone with the United States Securities and Exchange Commission (SEC) declaring its Form S-3 effective as of April 17, 2024, at 4:00 P.M. The Form S-3 is a registration form that allows companies to provide updated financial information and securities offerings to potential investors. This notice of effectiveness indicates that Biora Therapeutics has met all the regulatory requirements set forth by the SEC, paving the way for future securities offerings.

Biora Therapeutics, Inc., known in the stock market as BIOR.US, has achieved a significant milestone with the United States Securities and Exchange Commission (SEC) declaring its Form S-3 effective as of April 17, 2024, at 4:00 P.M. The Form S-3 is a registration form that allows companies to provide updated financial information and securities offerings to potential investors. This notice of effectiveness indicates that Biora Therapeutics has met all the regulatory requirements set forth by the SEC, paving the way for future securities offerings.